<SEC-DOCUMENT>0001628280-21-000216.txt : 20210209
<SEC-HEADER>0001628280-21-000216.hdr.sgml : 20210209
<ACCEPTANCE-DATETIME>20210106171549
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001628280-21-000216
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i807c419a7d8346ecb9e4f27a7371599a_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="cumberlandlogo1a.jpg" src="cumberlandlogo1a.jpg" style="height:79px;margin-bottom:5pt;vertical-align:text-bottom;width:280px"></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2525 West End Avenue, Suite 950</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nashville, Tennessee 37203</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 6, 2021</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VIA EDGAR </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Chris Edwards</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Securities and Exchange Commission</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Division of Corporation Finance</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100 F. Street, N.E.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Washington, D.C. 20549</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Re&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cumberland Pharmaceuticals, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Registration Statement on Form S-3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;File Number 333-251308</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Request for Acceleration of Effectiveness</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cumberland Pharmaceuticals, Inc. (the &#8220;Registrant&#8221;) hereby requests acceleration of the registration statement on Form S-3 (File No. 333-251308) to 4&#58;00 p.m., Eastern Time, on January 8, 2021 or as soon as practicable thereafter.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this request, the Registrant acknowledges that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">should the Securities and Exchange Commission (the &#8220;Commission&#8221;) or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing&#59; and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Registrant may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please contact our legal counsel, Tonya Mitchem Grindon, of Baker, Donelson, Bearman, Caldwell &#38; Berkowitz, PC, at (615) 726-5607, if you have any questions concerning this request.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Very truly yours,</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals, Inc.</font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:55.929%"><tr><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A.J. Kazimi</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.J. Kazimi</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman of the Board and Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>cumberlandlogo1a.jpg
<DESCRIPTION>CORRESP
<TEXT>
begin 644 cumberlandlogo1a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#R17AI9@  34T *@    @ ! $[  (
M   -   (2H=I  0    !   (6)R=  $    :   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $1A;BY,:6-K
M=&5I9P    60 P "    %   $*:0!  "    %   $+J2D0 "     S,U  "2
MD@ "     S,U  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ ^D:*** "BBC(]: "BC-&1ZT
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M*3)/M]: '44PD]N>:=DT +13<YZ4$M^M "XHQ29/XT9]:-0'8HIN3GGBES0
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MBMICB.7=D@'H2*Z8'@$=QS3;>P[(XGXC?#:S\<::6!^S:E&#Y-PG!^A]JU/
M/AZY\,>#;'2KYU>>W7#LG0U(GB^SE\3-HRHX<#"S_P #-_=!]:W6?:CMCA1D
MT^:7+RL#R3Q)\.O%K?$BY\3^%M0@MGEA$>'%)+X3^+%[&8)_$UO#'(-KM&.0
M/:O3M%UB+7+)KFW1D1)6C.[U%.U?5H-$T>YU*[W&*W0NP49)Q5>TE'2PCG/A
M_P##NS\#6\S>>UY?W1W3W3_><UVE<_X?\176M-NETXV\+KOCD\S=N%= *SEJ
M[L8M%%%2 4444 %(1FEHH KW5G#>0-#<PI,C#E7&17,WWPXT"\.4@:W/_3)L
M5UU)0!X[XV#_  HM+;4]!_TF>ZD\EEG.0!5;1OB?XAU;9YP@AW'G8,_SJ]^T
M'%)/X<TJ&WB>6:2[Q&B#DGBLWPA\.?$'DQ3W:1V@*YV.<M7;#D]G>1#;N=_]
MKN;G0_M%Q<MDC^'Y:Y2R\(R^*-8$UT9/L4399Y#DN?3Z5W]EX?\ )MTBNY1*
M%ZKCBM>*%(4$<:A$'10*YN9)NQ0D,"PVR0Q*%C10H4= !7.^*?"[^(-4TJ1B
M#!:REY%R02/PKJ!^E+6:?491L-)L],C>.Q@6(.VYB.I/KFL37O"W]M^)M.O;
MA5:VM8V5EW$$D_2NHHIW Y?2/"QTCQ5=W]MM6VFB"*F22#3_ !;H-]XCM8-.
MANOLUHSAKF0?>*C^$5TM&*+@<9;>$-1TGQ-!JECJ+7 =!%=), -RCA<8]*U_
M%>CSZWX;N-/M657E(^_R,9YK<HHN*QQOA_P:WAS7A<6:J]M-$%E$C%FB8#^$
MGH*U_%&DSZSI M;8JK^8I)89& >:VZ*.:[N,X&3P%=M>WL8N$;3/+8V=N1S'
M*WWC_A74Z'ITVG>'[.SG(>6"/:Q!ZFM6BFW<#AY/!%]JM]J%[J6I/!)=@Q!8
M5&!%V'/>MKPGI6H:+HXTZ_G$Z6S%()OXF3MGWK>I:5^@'(76A:KI'BBYUG03
M%-'?*!=6\O7(& RFMO1Y-5FCDDUB*&(L?W:1G)4>YK3-%&X'(>,/#][JNIZ?
M>64$4XMLJ\4C$9!]Q6MX;M[NUTYH;NUCMB')5$8L,?C6S2T7 Y/7=%U./Q1:
MZ_HOERR11&*:WE_C4]"#ZU)X7T._L]1U#5M6,8NKY\^5$3MC'ISWKIS10!E^
M(=-FU70KFS@*K)*N 6Z5/I-I)8Z3:VTN"\42HQ7ID5>HHOT Y_4-%N;CQEIF
MJQNOD6L4B.IZDL.#5CQ'H@U[1Y+3=L?(>-NP8=,^U;!I* .6LY?%@\BUFMK-
M/+PLEP"<,!Z"MG4XKUM+G&FE!>,F(V?. ?6M"C% 'G?_  K:\BT:%+?69OMD
M,OVE=P&WS<Y//7%=U EP]BGV@*L[1X<+T#8JW11>X'%>'[+Q)H;RV?V6VEM9
M+EI/,W$$ UU&HP2S:=,D$4,TC)@1SC*,?0^U7**-Q'%>'/#NI6?B#[:T26%K
MLP]M'(6#MZ@'@"NU%%%#=QBT444@"BBB@ HHHH *,444 4-0TBVU&ZM)[E _
MV5BZ C/)[U=5<')ZTZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
"_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
